Current Research Studies

TransIT: A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia

TransIT: Phase III

Condition(s): BMT
Phase: III
Clinicaltrials.gov ID: NCT05600426

What is the goal of the study?

This is a randomized trial comparing up front unrelated bone marrow transplant with immune suppressive therapy for newly diagnosed pediatric/young adult patients with severe aplastic anemia to compare time from randomization to treatment failure or death from any cause.

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

PI (Study Doctor): Madhavi Lakkaraja
Study Team Member: Courtney Vandervlugt, cperry@seattlechildrens.org

Seattle Children’s complies with applicable federal and other civil rights laws and does not discriminate, exclude people or treat them differently based on race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry), age, disability, or any other status protected by applicable federal, state or local law. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.